Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 448, 121 (12 July 2007) | doi:10.1038/448121a; Published online 11 July 2007
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Admission for Research Scholars Program
- CDFD (Centre for DNA Fingerprinting and Diagnostics)
- Hyderabad, A.P. 500 001 India
John Innes Centre Project Leader in Plant or Microbial Sciences
- University of East Anglia
- Norwich, NR4 7TJ, UK
In brief
Abbott Laboratories, the Illinois-based drug company, reached agreement with the Brazilian government to sell its AIDS drug Kaletra there for a reduced price — lifting the threat that Brazil might license it compulsorily. On 4 July, the company said it would sell it there for $1,000 per patient per year, down by about 30%.
To read this story in full you will need to login or make a payment (see right).
